We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 546

Tech interests praise USPTO director nomination
  • Shook Hardy & Bacon LLP
  • USA
  • October 30 2014

According to a news source, technology industry interests have lauded President Barack Obama's (D) choice for U.S. Patent and Trademark Office


Biotech boards dominated by men
  • Shook Hardy & Bacon LLP
  • USA
  • October 30 2014

A Liftstream analysis reportedly shows that the average Board of Directors in the biotechnology sphere is roughly 90 percent male and more than half


News bytes
  • Shook Hardy & Bacon LLP
  • USA
  • October 30 2014

The U.S. Food and Drug Administration (FDA) makes available Guidance for Industry titled "Circumstances that Constitute Delaying, Denying, Limiting


Third Circuit revives shareholder suit over dissolved biotech company
  • Shook Hardy & Bacon LLP
  • USA
  • October 30 2014

A divided Third Circuit Court of Appeals panel has reversed a district court ruling dismissing a shareholder's lawsuit against individuals and a


News Bytes
  • Shook Hardy & Bacon LLP
  • USA
  • February 13 2014

The U.S. Patent and Trademark Office requests comments by March 3, 2014, on the revision of a previously approved information collec- tion concerning


Consumer-fraud class action filed against 23andme after FDA action
  • Shook Hardy & Bacon LLP
  • USA
  • December 12 2013

Citing the Food and Drug Administration's (FDA's) November 22, 2013, warning letter, a California resident has filed a putative class action against


President signs compounding-pharmacy legislation; FDA rolls out draft guidance
  • Shook Hardy & Bacon LLP
  • USA
  • December 12 2013

Shortly after President Barack Obama signed the Drug Quality and Security Act (H.R. 3204) into law, the U.S. Food and Drug Administration (FDA


Federal court enjoins enforcement of Massachusetts opioid regulations
  • Shook Hardy & Bacon LLP
  • USA
  • July 17 2014

A federal court in Massachusetts has issued a preliminary injunction in a challenge to the Commonwealth's regulation of a specific opioid


Hearing on OTC drug review scheduled
  • Shook Hardy & Bacon LLP
  • USA
  • February 27 2014

The U.S. Food and Drug Administration (FDA) will conduct a public hearing on March 25-26, 2014, in silver spring, Maryland, "to obtain information


NIH to fund research centers targeting genetic causes of CHD
  • Shook Hardy & Bacon LLP
  • USA
  • July 17 2014

The National Institutes of Health (NIH) will award more than $2 million in fiscal year 2015 to research centers that will join the Pediatric Cardiac